Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05922722 · ClinicalTrials.gov registry record
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 200
- Enrollment target
NCT05922722 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 200 participants.
The verdict
NCT05922722 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase medication adherence. Participants will be asked to complete questionnaires that assess their understanding of the decision-making tool.
Interventions
- OTHER Questionnaire
- OTHER Decision-making tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2025-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05922722
The ClinicalTrials.gov registry entry for NCT05922722 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT05922722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05922722 about?
NCT05922722 is a clinical study titled "Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus". The purpose of this research study is to collect information from lupus patients about their experience with a tool that informs patients about the benefits vs. harms of a medication such as hydroxychloroquine. The main question it aims to answer is whether the decision-making tool will increase med...
What is the current status of trial NCT05922722?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2024-02-15. Estimated completion is 2025-02-20.
What interventions are being tested in trial NCT05922722?
The interventions under investigation include: Questionnaire (OTHER), Decision-making tool (OTHER).
Who is sponsoring clinical trial NCT05922722?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.